gdc-0973 has been researched along with Leukemia--Hairy-Cell* in 1 studies
1 other study(ies) available for gdc-0973 and Leukemia--Hairy-Cell
| Article | Year |
|---|---|
Targeting MEK in vemurafenib-resistant hairy cell leukemia.
Topics: Aged; Antineoplastic Agents; Azetidines; Drug Resistance, Neoplasm; Humans; Leukemia, Hairy Cell; Male; MAP Kinase Kinase 1; Piperidines; Prognosis; Salvage Therapy; Vemurafenib | 2019 |